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Genomic replication of the negative-strand RNA viruses is dependent upon protein synthesis. To examine
the requirement for protein synthesis in replication, we developed an in vitro system that supports the
genome replication of defective interfering particles of the negative-strand rhabdovirus vesicular stomatitis
virus (VSV), as a function of protein synthesis (Wertz, J. Virol. 46:513-522, 1983). The system consists of
defective interfering nucleocapsid templates and an mRNA-dependent reticulocyte lysate to support protein
synthesis. We report here an analysis of the requirement for individual viral proteins in VSV replication.
Viral mRNAs purified by hybridization to cDNA clones were used to direct the synthesis of individual
proteins in the in vitro system. By this method, it was demonstrated that the synthesis of the VSV
nucleocapsid protein, N, alone, resulted in the replication of genome-length RNA by both defective
interfering intracellular nucleocapsids and virion-derived nucleocapsids. Neither the viral phosphoprotein,
NS, nor the matrix protein, M, supported RNA replication. The amount of RNA replication for a given
amount of N protein was the same in reactions in which either all of the VSV proteins or only N protein
were synthesized. In addition, RNA replication products synthesized in reactions containing only newly
made N protein assembled with the N protein to form nucleocapsids. These results demonstrate that the
major nucleocapsid protein (N) can by itself fulfill the requirement for protein synthesis in RNA replication
and allow complete replication, i.e., initiation and elongation, as well as encapsidation of genome-length
progeny RNA.
Vesicular stomatitis virus (VSV) is one of the simplest of
the enveloped, nonsegmented, negative-strand RNA viruses
(5). The genome of VSV codes for five proteins that are
structural components of the virion. The RNA genome,
coated with the major nucleocapsid protein (N) and associat-
ed with the phosphoprotein (NS) and the RNA-dependent
RNA polymerase (L), forms the viral nucleocapsid. The
remaining viral proteins are the matrix protein, M, which is
located on the inside surface of the viral membrane, and the
glycoprotein, G, which is embedded in the membrane. The
viral nucleocapsids are capable of carrying out both RNA
replication and transcription. These processes can be distin-
guished from one another by their requirement for protein
synthesis (14, 23). Transcription involves the synthesis of a
46-base-long leader RNA and five monocistronic mRNAs
and does not require protein synthesis. In contrast, replica-
tion involves the synthesis of genome-length RNA and
requires the synthesis of viral proteins.
We have previously described an in vitro system which
supports VSV RNA replication, transcription, and nucleo-
capsid assembly (4, 12). This system, consisting of viral
nucleocapsids and a micrococcal nuclease-treated rabbit
reticulocyte lysate, replicates VSV RNA when protein syn-
thesis is programmed by the addition of viral mRNA. In the
work described in this report, we used nucleocapsids of a
VSV defective interfering particle (DI-T) which contain only
the 5' 25% of the standard genome (10, 20) as templates in
the in vitro system. This has been done to yield a system in
which genome-length RNA replication can be analyzed in
the absence of any mRNA synthesis (21). These DI nucleo-
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capsids do not synthesize mRNAs because they lack com-
plete information for all of the structural genes; only a 46-
base-long leader RNA is synthesized in the absence of
protein synthesis (6, 17. 21). Since no mRNAs are made by
the DI nucleocapsids, protein synthesis and, hence, RNA
replication in this system can be controlled by the addition of
exogenous mRNA. Therefore, by adding individual VSV
mRNAs to program the expression of individual viral pro-
teins, it has been possible to investigate the requirement for
each of the VSV proteins in RNA replication.
The above studies have been performed using DI nucleo-
capsids isolated from the cytoplasm of infected cells (intra-
cellular) and DI nucleocapsids prepared from budded DI
virions (virion-derived). Intracellular nucleocapsids contain
both positive- and negative-strand RNA templates and direct
the synthesis of both positive- and negative-strand genome-
length RNA in vivo (19). These templates within the infected
cell contain the enzymatic activities and the nascent progeny
RNAs associated with active replicating complexes (18).
Nascent RNAs may remain associated with the purified
intracellular nucleocapsids added to the in vitro system to
program RNA synthesis. In contrast, virion-derived nucleo-
capsids contain only negative-strand RNA, the template for
the synthesis of genome-length positive-strand RNA. Stud-
ies of virion RNA transcription in vitro indicate that there
are no nascent RNAs associated with virion-derived nucleo-
capsids (3). Therefore, whereas synthesis of genome-length
RNA by intracellular nucleocapsids in vitro may represent
both de novo synthesis and elongation of nascent RNAs, the
synthesis of genome-length RNA by virion-derived nucleo-
capsids represents only de novo synthesis.
We have used both intracellular and virion-derived nu-
cleocapsids in the in vitro replication system in conjunction
with purified individual mRNAs to examine the protein
synthesis requirement for VSV RNA replication.
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MATERIALS AND METHODS
Cell culture and virus. Monolayers of baby hamster kidney
cells (BHK-21/13) were maintained in Eagle minimal essen-
tial medium containing 5% heat-inactivated calf serum. VSV
(Indiana serotype) propagated in BHK cells (21) was used as
helper virus. Stocks of the DI particle of VSV, DI-T (VSV-
DI 0.25 (5'), 5' 25% of standard genome), were kindly
provided by R. Lazzarini (National Institutes of Health,
Bethesda, Md.).
Preparation of purified VSV mRNAs. cDNA clones of
VSV N, NS, and M mRNAs (7, 16), gifts of J. Rose (The
Salk Institute, San Diego, Calif.), in the Escherichia coli
plasmid pBR322 were used to select (15) N, NS, and M
mRNAs from VSV-infected cell polyadenylated RNA (4).
Plasmids were digested with restriction enzyme PstI, boiled
for 3 min, adjusted to 10x SSC (1 x SSC = 0.15 M NaCl and
0.015 M sodium citrate), and applied to preboiled, 13-mm
nitrocellulose filters (10 pLg DNA per filter). Each filter was
then dried, baked at 80°C for 2 h, boiled for 1 min, dried, cut
into eight pieces, and incubated in the presence of approxi-
mately 15 pLg of polyadenylated infected-cell RNA, 65%
formamide (Fluka), 40 mM PIPES [piperazine-N,N'-bis(2-
ethanesulfonic acid)] (pH 6.3), and 0.4 M NaCl in a final
volume of 100 [L for 3 h at 52°C in a 1.5-ml microfuge tube.
Filter sections in each tube were then washed 10 times with 1
ml of 1x SSC containing 0.5% sodium dodecyl sulfate and 3
times with 1 ml of 10 mM Tris (pH 7.4)-2 mM EDTA at 65°C.
Bound RNA was eluted by boiling filters in each tube for 2
min with 300 [L of water. The RNA in the supernatant was
precipitated in ethanol with 1 pLg of rabbit liver tRNA per
filter. The precipitate was suspended in 2 [L of water per
filter. The purity of the hybrid-selected mRNAs was mea-
sured by translating them in an mRNA-dependent rabbit
reticulocyte lysate in the presence of [35S]methionine and
analyzing the 35S-labeled products by electrophoresis on a
10% polyacrylamide gel (9). Fluorograms of the gels were
scanned with a laser densitometer (21). The ratio of expres-
sion of the protein encoded by the selected mRNA to that of
other viral proteins produced by the same preparation ex-
ceeded 1,000:1.
Components of in vitro replication system. A detailed
description of the components constituting the replication
system has been reported elsewhere (4). Reaction mixtures
contained micrococcal nuclease-treated reticulocyte lysate,
nucleoside triphosphates, creatine kinase, amino acids, salts,
dithioerythritol, purified VSV DI nucleocapsids, 1 ,uCi of
[3HJUTP per ,l, and 0.4 pLCi of [35Sjmethionine per R in a
final volume of 25 pA. Intracellular nucleocapsid templates
were prepared from BHK cells coinfected for 13 h with VSV
(multiplicity of infection = 2) and DI particles at a ratio
which gave 99% inhibition of standard virus yield, as de-
scribed previously (21). Virion-derived nucleocapsids were
prepared as follows. DI particles released into the medium of
the mixedly infected cultures were purified by velocity
sedimentation in a 16 to 30% (wt/wt) glycerol gradient
containing RSB (0.01 M Tris-hydrochloride, pH 7.4, 0.01 M
NaCl, 1.5 mM MgCl2). Membrane components were dissoci-
ated by treatment with 1.8% Triton X-100-0.43 M NaCl-0.6
mM dithioerythritol for 30 min at 30°C. The nucleocapsid
component (virion-derived nucleocapsids) was purified by
sucrose density gradient centrifugation exactly as described
for intracellular nucleocapsids (21). Reactions were pro-
grammed for protein synthesis by the addition of either
polyadenylated RNA isolated from VSV-infected cells or
individual hybrid-selected VSV RNAs as indicated. Reac-
tions were typically incubated for 3 h at 30°C.
Analysis of in vitro products. Samples (1 Rl) of each
reaction were analyzed by electrophoresis on 10% polyacryl-
amide gels containing sodium dodecyl sulfate as described
by Laemmli (9). 35S-labeled proteins were assayed by fluo-
rography of dried gels. Unless otherwise indicated, the
remainder of each reaction, after deproteinization with phe-
nol and sodium dodecyl sulfate, was analyzed for 3H-labeled
RNA by electrophoresis on agarose-urea gels (22). Analysis
of products by CsCl gradient centrifugation has been de-
scribed previously (4).
RESULTS
Ability of N, but not NS or M, proteins individually to
support VSV RNA replication by intracellular nucleocapsids.
The protein requirement for synthesis of genome-length
RNA was examined by programming the in vitro system
with the individual hybrid-selected N, NS, or M mRNAs to
determine whether N, NS, or M proteins, when translated
individually in the presence of enzymatically active intracel-
lular nucleocapsids, could promote the synthesis of genome-
length RNA. Synthesis of viral RNA and proteins was
examined simultaneously in each reaction by double labeling
with [3H]UTP and [35S]methionine. Figure 1A shows the 3H-
labeled RNA products, and Fig. 1B shows the 35S-labeled
protein products of reactions programmed by varying
amounts of total VSV mRNA (lanes 2 through 5) or of
hybrid-selected N mRNA (lanes 6 through 8). Two addition-
al reactions contained hybrid-selected NS mRNA (lane 9) or
hybrid-selected M mRNA (lane 10). Synthesis of N protein
alone was sufficient for the synthesis of genome-length RNA
(Fig. 1). In addition, neither NS nor M proteins by them-
selves were able to support the synthesis of genome-length
RNA.
By densitometry, the levels of genome synthesis and N
protein expression were measured for each reaction contain-
ing total mRNA or N mRNA alone and plotted (Fig. 2). The
amount of genome synthesis was directly proportional to the
amount of N protein synthesis in both sets of reactions. A
detailed quantitation of the absolute amounts of RNA and
protein synthesized has been reported previously (21). Fur-
thermore, all of the points fell on a single straight line,
indicating that the efficiency of RNA replication for a given
amount of N protein synthesis in reactions containing either
all five VSV mRNAs or only N mRNA was equivalent. This
finding suggested that synthesis of the other VSV proteins
was not necessary for genome-length RNA synthesis, and
that, when produced in the relative amounts shown in Fig.
1A, lane 2, proteins other than N did not affect the level of
genome-length RNA synthesis.
In addition to genome-length RNA, faster-migrating
RNAs were also made in vitro. The relative amount of these
smaller RNAs varied with different nucleocapsid prepara-
tions. Since their synthesis depended on a source of N
protein (Fig. 1) and they were nuclease resistant (data not
shown), they were probably incomplete replicative prod-
ucts. The appearance of discrete bands rather than a contin-
uum of smaller RNAs suggested that there may be sites on
the template at which polymerization is attenuated or prema-
turely terminated.
Examination of the requirement for concurrent N protein
synthesis during VSV RNA replication. The ability of N
protein synthesized before the addition of nucleocapsid
templates (presynthesized N) to support genome-length
RNA synthesis was tested. A reaction programmed with N
mRNA and containing no nucleocapsid templates was incu-
bated for 45 min, and afterwards, anisomycin, a protein
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synthesis inhibitor, was added with nucleocapsid templates.
The incubation was continued for an additional 2 h and 15
min. The N protein made in the first 45 min and the RNA
products made during the following 2 h and 15 min (Fig. 1A
and B, lanes 11) were compared with those made in a 3-h
reaction in which RNA and protein were synthesized con-
currently (Fig. 1A and B, lanes 6 through 8). The results
showed that presynthesized N protein could support DI
RNA replication. However, when the level of genome-length
FIG. 1. Synthesis of genome-length RNA and viral proteins in
vitro in reactions containing intracellular nucleocapsids and pro-
grammed with total VSV mRNA or individual mRNAs. Reactions
contained both [3H]UTP and [35S]methionine and were incubated
for 3 h at 30'C. Samples (1 ,ul) were analyzed by polyacrylamide gel
electrophoresis for 35S-labeled proteins (B). The remainder after
deproteinization was analyzed for 3H-labeled RNAs by electropho-
resis on agarose-urea gels (4, 22) (A). RNA and protein products are
shown from a reaction containing no added VSV mRNA (lane 1);
from reactions containing 0.74 ,ug (lane 2), 0.185 ,ug (lane 3), 0.037
jig (lane 4), and 0.007 ,ug (lane 5) of total polyadenylated VSV
mRNA; from reactions containing 5 RI1 (lane 6), 1.25 RI1 (lane 7), and
0.3 ,ul (lane 8) of hybrid-selected N mRNA; from a reaction
containing 4 ,u1 of hybrid-selected NS mRNA (lane 9); and from a
reaction containing 4 ,ul of hybrid-selected M mRNA (lane 10).
Products in lane 11 are from a reaction in which 4 p.l of hybrid-
selected N mRNA was translated for 45 min and then nucleocapsids
and anisomycin were added for 2 h and 15 min. RNA purified from
DI intracellular nucleocapsids labeled in vivo with [3H]uridine is
shown in lane 12. The positions of 3H-labeled VSV mRNAs run in a
parallel lane are indicated. The full-length RNA product (X) derived
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FIG. 2. Correlation of genome-length RNA synthesis and N
protein expression. Fluorograms shown in Fig. 1 were analyzed by
densitometry. Exposure times were chosen to give band intensities
in the linear range (21). The relative absorbance units of 35S-labeled
N protein for a given reaction are plotted versus the total amount of
genome-length RNA (plus and minus strands) synthesized in that
reaction. Results are shown from reactions to which varying
amounts of total VSV mRNA (@) or hybrid-selected N mRNA (0)
were added. The line has been fitted with a correlation coefficient of
0.995 to the results from reactions containing total VSV mRNA,
using a least-squares analysis.
RNA synthesis and the level of presynthesized N protein
were measured, it was observed that the amount of genome-
length RNA synthesized per unit of N protein in reactions
containing only presynthesized N protein was not more than
25% of that expected based on results of reactions in which
N protein and RNA were synthesized simultaneously.
Ability of N protein, alone, to support RNA replication by
nucleocapsids from budded DI particles. We used the in vitro
replication system to determine whether DI nucleocapsids
purified from budded virions, i.e., virion-derived nucleocap-
sids, in contrast to intracellular nucleocapsids, required the
synthesis of a viral protein(s) in addition to N protein to
produce genome-length RNA. DI virion-derived nucleocap-
sids were purified away from membrane components (see
above) to give templates consisting of negative-strand RNA
in association with N, NS, and L proteins (data not shown).
Reactions contained the reticulocyte lysate, extracellular
nucleocapsids, [3H]UTP, [35S]methionine, and either total
VSV mRNA or hybrid-selected N mRNA. Analysis of the
RNA products showed that in the absence of added VSV
mRNA, no genome-length RNA was made (Fig. 3, lane 4).
When protein synthesis was programmed by adding total
VSV mRNA, genome-length positive-strand RNA was syn-
thesized from the negative-strand RNA template (Fig. 3,
lane 5). The inhibition of protein synthesis by anisomycin
completely blocked genome-length RNA synthesis (Fig. 3,
lane 7). The addition of N mRNA alone resulted in the
synthesis of genome-length positive-strand RNA (Fig. 3,
lane 6). Thus, N protein alone fulfilled the protein synthesis
requirement for RNA replication.
Quantitation of the levels of RNA replication (Fig. 3) and
N protein synthesis (data not shown) in the reactions pro-
grammed with total VSV mRNA or N mRNA alone showed
that equal amounts of N protein and equal amounts of
genome-length RNA were made in the two reactions. Thus,
no detectable stimulation of genome-length RNA synthesis
occurred when viral proteins in addition to N were synthe-
sized. In summary, VSV DI nucleocapsids, whether purified
from budded DI virions or from infected cells, required only
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FIG. 4. Assembly of newly synthesized N protein into nucleo-
capsids in vitro. Reaction mixtures containing DI intracellular
nucleocapsids and either 1 ,ul of total polyadenylated VSV-infected
cell RNA or 3 ,ul of hybrid-selected N mRNA were incubated at
30°C for 3 h and then adjusted to 0.05% Nonidet P-40 and centri-
fuged through a 15 to 30% sucrose gradient (21). 35S-labeled proteins
in fractions from the gradients were analyzed by polyacrylamide gel
electrophoresis and fluorography. The fluorograph shows the 35S-
labeled proteins that remained at the top of gradients (lanes 1 and 4)
or those which cosedimented with authentic nucleocapsids (lanes 2
and 5) from reactions programmed with total infected-cell RNA
(lanes 1 and 2) or hybrid-selected N mRNA (lanes 4 and 5). 35S-
labeled protein products from reactions containing no nucleocapsids
and total infected-cell RNA (lane 3) or hybrid-selected N mRNA
(lane 6) that cosedimented to the position of authentic nucleocapsids
are shown.
FIG. 3. Synthesis of genome-length RNA in vitro directed by
nucleocapsids prepared from budded DI virions. Virion-derived
nucleocapsids were used as templates for RNA synthesis in the in
vitro replication system described in Fig. 1. 3H-labeled RNA
products, separated by agarose-urea gel electrophoresis, are shown
from reactions containing no mRNA (lane 4), total VSV mRNA
(lane 5), hybrid-selected N mRNA (lane 6), or total VSV mRNA
plus 25 p.M anisomycin (lane 7). Markers labeled with [3H]uridine in
vivo are total polyadenylated VSV mRNA (lane 1), genome RNA
from purified intracellular nucleocapsids (lane 2), and genome RNA
from virion-derived nucleocapsids purified in parallel with unlabeled
template nucleocapsids (lane 3).
Production of nucleocapsids in the presence of only N
protein and newly replicated RNA. In infected cells, newly
replicated VSV RNA rapidly assembles with viral proteins
to form nucleocapsids. These nucleocapsids render the RNA
resistant to degradation by RNase (19) and band at a specific
density in CsCI (1.30 g/cm3). We determined whether N
protein alone was sufficient for nucleocapsid assembly or
whether other VSV proteins might be required for this
process. To assay for nucleocapsid assembly in reactions
programmed with only N mRNA, replication products were
tested for (i) the presence of newly synthesized N protein,
(ii) nuclease resistance, and (iii) the ability to band in CsCl at
the density of authentic nucleocapsids.
(i) Intracellular nucleocapsids were isolated from reac-
tions incubated with either total VSV mRNA or N mRNA
alone by velocity sedimentation in sucrose gradients. 35S-
labeled protein products which remained at the top of the
gradient and those which sedimented with nucleocapsids
were analyzed by polyacrylamide gel electrophoresis (Fig.





FIG. 5. Nuclease resistance of RNA products produced in reac-
tions containing intracellular nucleocapsids programmed with hy-
brid-selected N mRNA. Reaction mixtures containing DI nucleo-
capsids and either 2 p.l of total polyadenylated RNA (lanes 1 and 2)
or 4 p.l of hybrid-selected N mRNA (lanes 3 and 4) were incubated at
30°C for 3 h. 3H-labeled polyadenylated RNA isolated from VSV-
infected cells was then added to serve as an internal control for the
nuclease treatment, and the reactions were divided into two equiva-
lent fractions. CaCl2 was added to one fraction to give an additional
3.6 mM Ca2 , micrococcal nuclease was added to 20 p.g/ml, and the
reaction was incubated for 15 min at 20°C (lanes 1 and 3). The
second fraction was incubated likewise but in the absence of added
CaCl, and micrococcal nuclease. Afterwards, both halves were












FIG. 6. Equilibrium density gradient centrifugation of RNA and protein products made in the presence of N mRNA alone. In vitro reaction
mixtures programmed with N mRNA alone and containing Di intracellular nucleocapsids (A) or virion-derived nucleocapsids (B) were banded
in CsCI as described previously (4). Gradient fractions were assayed for 35S-labeled protein bv trichloroacetic acid precipitation. Radiolabeled
products contained in the peak at nucleocapsid density (fractions 16 through 18) were concentrated by pelleting and extracted with phenol. (C)
The purified. CsCI-banded, 'H-labeled RNAs made in reactions containing intracellular nucleocapsids (lane 3) or virion-derived nucleocap-
sids (lane 4) and N mRNA alone were analyzed by agarose-urea gel electrophoresis. Genome RNA markers were from Dl intracellular (lane 1)
or virion-derived (lane 2) nucleocapsids labeled with [3H]uridine in vivo.
4). Nucleocapsids recovered from a reaction programmed
with total VSV mRNA contained 35S-labeled N and NS
proteins (Fig. 4, lanes 1 and 2) as we previously reported for
standard VSV (12). L protein was not synthesized in detect-
able amounts in this experiment. Results obtained from the
reaction programmed with N mRNA alone (Fig. 4, lanes 4
and 5) showed that newly synthesized N protein assembled
into nucleocapsids in the absence of any other newly synthe-
sized viral proteins.
(ii) Genome-length RNAs synthesized in a reaction con-
taining intracellular nucleocapsids were treated with micro-
coccal nuclease in the reaction mixture after the addition of
Ca2 + and 3H-labeled purified mRNAs as internal controls for
nuclease activity. Genome-length RNA made in the reaction
with N mRNA alone, like that made in the control reaction
with total VSV mRNA (see also reference 21). was resistant
to digestion under conditions in which mRNA in the same
preparation was completely digested (Fig. 5).
(iii) Additionally, reaction mixtures programmed with only
N mRNA and with either DI intracellular or virion-derived
nucleocapsids were assayed for the presence of products
which banded at the position of nucleocapsids in CsCl
gradients. A large proportion of the newly synthesized N
protein banded at the position of authentic nucleocapsids
(Fig. 6A and B). Neither free N protein nor RNA banded at
this position. 3H-labeled RNA isolated from the peaks at
nucleocapsid density included negative- and positive-strand
genome-length RNA or positive-strand genome-length RNA
for reactions containing intracellular or extracellular nucleo-
capsids. respectively (Fig. 6C, lanes 3 and 4). An identical
pattern of CsCl-banded RNA products was obtained from
reactions programmed with total VSV mRNA (data not
shown). Therefore, we conclude that the assembly of stable,
nuclease-resistant nucleocapsids is solely dependent upon N
protein.
DISCUSSION
We have used hybrid-selected VSV mRNAs in an in vitro
replication system to determine which of the viral proteins
are required for the synthesis and encapsidation of VSV
genome-length RNA. The synthesis of N protein alone by
the reticulocyte lysate in reactions containing either intracel-
lular or virion-derived nucleocapsid templates supported the
synthesis of DI genome-length RNAs. In our reactions, N
protein alone was as efficient in supporting VSV replication
as the same amount of N protein in reactions containing all
five viral proteins. In addition, N protein, by itself, was able
to associate with genome-length RNA to yield stable, nucle-
ase-resistant, nucleocapsid-like structures. The results pre-
sented demonstrate that the major nucleocapsid protein, N,
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RNA replication and promotes the assembly of VSV nucleo-
capsids.
Virion-derived nucleocapsids, like intracellular nucleo-
capsids, are capable of synthesizing a 46-base leader RNA in
vitro without a source of viral proteins (6, 21), and results
presented here and elsewhere (13, 21) show that both can
direct the synthesis of genome-length RNA in vitro when a
source of viral proteins is provided. Results reported previ-
ously by Chanda and Banerjee (3) suggest that virion-derived
nucleocapsids contain no nascent RNAs. They observed
that "incomplete" in vitro transcription reactions containing
detergent-disrupted VSV virions, ATP, GTP, and [cr-
3-P]CTP produced radiolabeled oligonucleotides which var-
ied in length from a few nucleotides to approximately 28
bases. Longer products, which would be expected from
limited elongation at the 3' ends of longer nascent progeny
RNAs, were not detected either as a continuous slower-
migrating background or as products which were too large to
enter the 20% polyacrylamide gel. These findings make it
unlikely that nascent RNAs are packaged in VSV virions.
Hence, the synthesis of genome-length RNA by virion-
derived nucleocapsids in our replication system in the pres-
ence of N protein alone demonstrates that new N protein
fulfills the protein synthesis requirement for de novo RNA
replication.
It has been proposed that the region of the template
immediately following the leader gene acts to attenuate RNA
synthesis unless a source of N protein is provided (1, 8, 11).
Our results are consistent with this hypothesis. However,
since the in vitro reaction mixture included nucleocapsids
which carried NS and L proteins, it is possible that one of
these proteins might perform a unique function at the
postulated attenuation site. In any case, we have proven that
a source of newly synthesized viral protein other than N is
not necessary to obtain read-through of any proposed atten-
uation site.
The data presented here have also shown that VSV does
not require the concurrent synthesis of N protein for RNA
replication. The reason for the decreased efficiency of N
protein synthesized in reactions before the addition of nu-
cleocapsid templates in supporting RNA replication is un-
known. It is possible that "premade" N protein self-assem-
bles (2) in our system, thereby reducing the concentration of
N protein available to drive replication. Alternatively, N
protein may undergo post-translational modification such
that it is capable of promoting RNA replication for only a
short period of time after it is synthesized.
Previously, Blumberg et al. (2) used reconstitution experi-
ments to demonstrate that N protein was able to assemble
with leader RNA into nucleocapsid-like structures in the
absence of other viral proteins. Our results indicate that N
protein, by itself, is also able to assemble with genome-
length RNA into structures that are indistinguishable from
VSV nucleocapsids. We cannot rule out the possibility that
small amounts of viral proteins in addition to N are neces-
sary for nucleocapsid assembly and that they are being
provided to the in vitro system by the nucleocapsid tem-
plates added into the reactions to direct RNA synthesis.
In summary, we have used an in vitro system to define the
requirement for the synthesis of proteins in VSV RNA
replication. Our results show that nucleocapsid templates
which contain the enzyme components L and NS require
only a source of new N protein to synthesize genome-length
RNA. Thus, VSV RNA replication does not require the
synthesis of a new core polymerase, L, or phosphoprotein,
NS. Although these data show that new viral proteins other
than N are not required for RNA replication, further experi-
ments are necessary to determine whether other VSV pro-
teins may have a role in regulation of this process.
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